Market Research

NEJM conducts independent market research to track physicians’ content consumption and prescribing habits and makes this information available to advertisers free of charge. These independent studies are now available:

Value of Advertising in Peer Reviewed Journals Study, NEJM Group, 2023

Examines how NEJM readers view and engage with peer-reviewed journals compared to non–peer-reviewed print publications, particularly as it relates to print advertisements and prescribing habits.

Specialties measured include: Cardiology, Gastroenterology, Hematology-Hematology/
Oncology-Oncology, Infectious Diseases, Nephrology, Neurology, Pulmonology, Rheumatology

NEJM Trust and Value Survey, 2022

Released in July 2022, this survey measures NEJM against select top competitors on the following attributes: trust, practice influence, credible, and accessibility of information.
The survey also evaluates the likelihood of physicians to change their practice habits based on clinical trial information published in its original form in a medical journal versus being summarized by a medical news source or pharmaceutical company.

U.S. Essential Journal Study Update, 2021*

The Essential Journal Study is a unique series of studies conducted for over 30 years among the universe of internists and internal medicine subspecialists. It’s an indispensable tool for pharmaceutical marketers as it identifies the “must-read” journals that physicians consider essential to their practice and provides additional insights into physicians’ content preferences and consumption behaviors.

*The 2019 Essential Journal Study was updated with additional survey
results in 2021.

Brand Funnel Study, 2020

This independent study of the physician universe focuses on physician awareness, familiarity, and satisfaction with leading medical journals across important internal medicine subspecialties, including cardiology, oncology, and infectious diseases. For
your copy, contact your Sales Director.

Physicians Trust in Medical Journals, 2018

Sources of medical information are growing exponentially. NEJM Group commissioned a market research study to determine physicians’ level of trust among the leading medical journals in nine specialties.

For each journal, physicians measured their level of trust for the following:
• Learning about changes and breakthroughs in therapies
• Preparing to discuss treatment therapies with their peers
• Helping to educate patients about treatment options
• Influencing their clinical decisions
In every specialty, a physician’s degree of trust in a
publication correlated very strongly with readership.

NEJM also subscribes to Kantar Media and Media Radar.